Notifications
Back

The Eloquence® Collection is a premium range of monophasic hyaluronic acid dermal fillers developed to deliver natural-looking, long-lasting aesthetic results. Eloquence is known for its exceptional quality, safety, and clinical performance.

Eloquence Fine is ideal for lip augmentation, correction of perioral wrinkles, and improvement of infraorbital hollowing.
Eloquence Deep is designed for deeper injections to restore cheek volume, address age-related mid-face volume loss, and smooth moderate to severe facial wrinkles and folds, including nasolabial folds.
Eloquence Sub-Q enhances jawline and nasal contours and is particularly effective in cases of moderate to severe loss of jawline definition.
For body contouring, Eloquence Body, Body Plus, Contour, Shape, and Flow are developed for hypodermic injection to restore volume and enhance areas such as the buttocks, hands, calves, and chest.

Eloquence Face Collection1.1ml

Eloquence Triple Sub-Q3 ml x 3 Syringes

Eloquence Contour10 ml / 1 Syringe

Eloquence Body Plus100ml / 1 vial

Eloquence Body60ml / 1 vial

Eloquence Shape55ml / 1 syringe

Eloquence Flow106ml / IV-Type Bag

ELOQUENCE

Collection of Fillers
More

Eloquence is the premier collection of Korean dermal fillers, featuring six unique products designed to meet your specific needs. Enhance facial volume with Eloquence Fine, Deep, and Sub-Q, or achieve body contouring with Eloquence Body, Contour, and Shape.

Eloquence Collection of Fillers - Important Information

Eloquence is the premier collection of Korean dermal fillers, featuring six unique products designed to meet your specific needs. Enhance facial volume with Eloquence Fine, Deep, and Sub-Q, or achieve body contouring with Eloquence Body, Contour, and Shape.


Whatever your goals, we have the solutions to help you achieve the results you desire.

INDICATIONS

Eloquence Fine injectable gel is designed for lip augmentation and the correction of perioral wrinkles, as well as improving infraorbital hollowing in adults aged 21 and older.


Eloquence Deep injectable is intended for deep (subcutaneous and/or supraperiosteal) injection to enhance cheek volume, address age-related deficits in the mid-face, and correct moderate to severe facial wrinkles and folds, including nasolabial folds, in adults over 21.


Eloquence Sub-Q injectable gel is suitable for subcutaneous and/or supraperiosteal injection to enhance jawline and nose definition in adults aged 21 and older, particularly for those experiencing moderate to severe loss of jawline definition.


Eloquence Body, Contour, and Shape injectable gel is indicated for hypodermic injection to augment the buttocks, hands, calves, and chest in adults over the age of 21 with moderate to severe loss of volume in these areas.

IMPORTANT SAFETY INFORMATION

These products are not recommended for individuals with severe allergies, particularly those with a history of anaphylaxis or multiple severe allergies. Additionally, they should not be used by patients who have a known allergy to Gram-positive bacterial proteins or lidocaine present in these formulations.

WARNINGS

  • Avoid injecting into blood vessels. Introducing these products into the vascular system can lead to serious complications such as embolization, vessel occlusion, ischemia, or infarction. When administering soft tissue fillers, exercise caution: after inserting the needle and just before injection, slightly withdraw the plunger to aspirate and confirm that the needle is not intravascular. Inject the product slowly and apply only the necessary amount of pressure. Although rare, serious adverse events related to intravascular injection of facial fillers have been reported, including temporary or permanent vision impairment, blindness, cerebral ischemia or hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. If a patient shows any signs of changes in vision, stroke symptoms, skin blanching, or unusual pain during or shortly after the procedure, immediately discontinue the injection and seek prompt medical attention, potentially involving a specialist.
  • Defer product use at sites with active inflammatory processes. This includes areas affected by skin conditions like cysts, pimples, rashes, or hives, until the underlying issue has been addressed and controlled.

PRECAUTIONS

  • To reduce the risk of potential complications, these products should only be administered by healthcare professionals who possess a thorough understanding of the relevant anatomy and the specific product(s) intended for use in designated areas. They should also have appropriate training in facial anatomy, vascular structures, safe injection techniques, and the identification and management of potential adverse events, including intravascular complications.
  • It is essential to discuss the potential risks associated with soft tissue injections with patients prior to treatment so they are aware of the signs and symptoms of possible complications.
  • The safety and effectiveness of these products for treating anatomical regions outside the indicated areas have not been established through controlled clinical studies. The safety of these products in patients with a known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied. The safety of these products during pregnancy and breastfeeding has not been established.
  • The safety of Eloquence has been confirmed for patients aged 35 to 65 for cheek augmentation and for patients aged 22 to 80 years. Dermal filler implantation carries an inherent risk of infection; therefore, standard precautions should always be followed. Caution is advised when using dermal fillers in patients undergoing immunosuppressive therapy.


  • Patients taking medications that can prolong bleeding, such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin, may experience increased bruising or bleeding at the treatment sites. Patients with skin injuries near the implantation site may be at a higher risk for adverse events.


  • If considering laser treatments, chemical peels, or any other procedures that provoke an active dermal response after treatment, or before the skin has fully healed from a prior procedure, there may be a risk of triggering an inflammatory reaction at the injection site.

ADVERSE EVENTS

The most frequently reported side effects of Eloquence injectable gels include redness, swelling, pain, tenderness, firmness, lumps or bumps, bruising, discoloration, and itching or dryness. Most of these effects were mild to moderate in severity.

Global Recognition & Industry Awards

Eloquence has been honored at AMWC (Aesthetic & Anti-Aging Medicine World Congress) - one of the most prestigious and respected congresses in aesthetic medicine worldwide. This recognition reflects the product’s clinical excellence, innovation, and strong reputation among aesthetic professionals globally.

Manufactured by Jetema – A Leader in Safety & Quality

Eloquence is manufactured by Jetema, one of South Korea’s leading aesthetic manufacturers, recognized for its strict quality control systems and commitment to product safety.

  • Advanced manufacturing technology

  • Stringent quality and safety standards

  • Focus on biocompatibility and consistency

  • Trusted global production expertise

Safety is a core priority in the development and production of the Eloquence Collection.

Advanced Monophasic Hyaluronic Acid Technology
ZEEP Technology - Zero Endotoxin & BDDE Entire Process

Eloquence is a monophasic hyaluronic acid filler, designed to provide smooth injection, even distribution, and predictable aesthetic outcomes.

  • Homogeneous gel structure for smooth tissue integration

  • Optimized viscoelastic properties for stability and lift

  • Designed for natural expression and refined contouring

Eloquence is developed using ZEEP Technology (Zero Endotoxin & BDDE Entire Process), a proprietary manufacturing approach focused on safety and purity.

  • Endotoxin level maintained below 0.1 EU/mL

  • No detectable residual BDDE

  • Reduced risk of post-procedure inflammatory reactions

By minimizing endotoxin levels and eliminating residual BDDE, Eloquence enhances patient safety and post-treatment tolerability.

The Downing Process – Uniform Particle Engineering 
Safety First with Minimized BDDE Input

Eloquence utilizes a unique Downing Process, producing a uniform particle size distribution within the HA gel.

  • Smooth and controlled injection

  • Enhanced precision during treatment

  • No particle agglomeration

  • Consistent clinical handling

This process allows practitioners to achieve refined, predictable results with excellent control.

The Degree of Modification (MoD) is a critical parameter for safety validation in HA fillers.

  • MoD is defined as:
    MoD = fully cross-linked BDDE + pendant-type BDDE

  • It represents the total BDDE content used to modify hyaluronic acid

Eloquence demonstrates an MoD approximately 1/6 lower than other monophasic fillers, contributing to an improved safety profile while maintaining clinical effectiveness.

Maximized Cross-Linking Efficiency
Superior Viscoelasticity & Cohesiveness

Through an advanced physical cross-linking process, Eloquence achieves optimal cross-linking efficiency while significantly reducing the amount of BDDE required as a chemical catalyst.

  • High cross-linking efficiency

  • Reduced chemical exposure

  • Gel enriched with superior viscoelastic properties

When compared with leading filler products, Eloquence exhibits viscosity and cohesiveness comparable to U.S. premium fillers, despite requiring lower BDDE input.

  • Excellent lifting capacity

  • Stable tissue support

  • Smooth, natural integration

This balance ensures consistent, high-quality clinical outcomes.

Safety Information

Dermal filler injections carry a small risk of unintentional injection into a blood vessel. Although rare, this may lead to serious complications, including vision disturbances, blindness, stroke, skin necrosis, or permanent scarring.

Seek immediate medical attention if you experience:

  • Sudden changes in vision

  • Symptoms of a stroke (such as difficulty speaking, weakness or numbness of the face or limbs, dizziness, confusion, or severe headache)

  • Severe or unusual pain during or after treatment

  • Whitening or discoloration of the skin at the injection site

The safety and effectiveness of Eloquence® products have not been established for use outside their intended indications or treatment areas. Use only by qualified and trained healthcare professionals.


Potential Side Effects

Common side effects are generally mild to moderate and may include:

  • Redness, swelling, pain, tenderness, or firmness at the injection site

  • Bruising, lumps or bumps, itching, or discoloration

  • Dryness or tightness of the skin

In rare cases, patients may experience muscle weakness, dizziness, vision disturbances, or headaches. Most side effects resolve within a few days to weeks. As with any injectable procedure, there is a risk of infection.

Do Not Use If You

  • Have a history of severe allergies or anaphylaxis

  • Are allergic to hyaluronic acid, lidocaine (if applicable), or any components of the product

  • Have previously experienced allergic reactions to dermal fillers

  • Have active skin infections, inflammation, rashes, cysts, or open wounds at or near the intended treatment area

Important Safety Warnings and Precautions

Dermal filler injections carry a small risk of unintentional injection into a blood vessel. Although rare, this may lead to serious complications, including vision disturbances, blindness, stroke, skin necrosis, or permanent scarring.

Seek immediate medical attention if you experience:

  • Sudden changes in vision

  • Symptoms of a stroke (such as difficulty speaking, weakness or numbness of the face or limbs, dizziness, confusion, or severe headache)

  • Severe or unusual pain during or after treatment

  • Whitening or discoloration of the skin at the injection site

The safety and effectiveness of Eloquence® products have not been established for use outside their intended indications or treatment areas. Use only by qualified and trained healthcare professionals.

Precautions

  • The safety of Eloquence® injectable gels during pregnancy or breastfeeding has not been established.

  • Patients with a history of excessive scarring or pigmentation disorders should use caution, as treatment may result in additional scarring or pigmentation changes.

  • Inform your practitioner if you are taking immunosuppressive medications, blood-thinning agents, or anti-inflammatory drugs, as these may increase the risk of infection, bruising, or bleeding.

  • If you are planning laser treatments, chemical peels, or other aesthetic procedures, discuss appropriate timing with your practitioner to reduce the risk of inflammation.

© 2025 Haim Aesthetics.  All rights reserved.

All trademarks are the property of their respective owners.

© 2025 Haim Aesthetics.  All rights reserved. All trademarks are the property of their respective owners.